Our previous studies demonstrate that LCN2 plays an inflammatory role in the WAT, liver, and hippocampus in animal models of metabolic disorders, including obesity, non-alcoholic fatty liver disease, and T2D [4,8,18]. This evidence concerns the gene LCN2 and obesity due to melanocortin 4 receptor deficiency.